Zobrazeno 1 - 10
of 96
pro vyhledávání: '"Xue‐Jun Guo"'
Autor:
Xue-Jun Guo, Xiao-Ting Cai, Zi-Xuan Rong, Yan-Pei Zhang, Yu-Xiang Wen, Xue Bai, Jian Wang, Qiang John Fu, Ze-Qin Guo, Li-Li Long, Si-Cong Ma, Xin-Ran Tang, Li Liu, Jian Guan, Zhong-Yi Dong, De-Hua Wu
Publikováno v:
BMC Medicine, Vol 21, Iss 1, Pp 1-12 (2023)
Abstract Background Immune checkpoint inhibitor (ICI) therapy combined with conventional therapies is being broadly applied in non-small cell lung cancer (NSCLC) patients. However, the risk of interstitial pneumonitis (IP) following a combined regime
Externí odkaz:
https://doaj.org/article/9b36884ce008485099683e8c140bc2c6
Autor:
Si-Cong Ma, Xue Bai, Xue-Jun Guo, Li Liu, Lu-Shan Xiao, Yan Lin, Jia-Le Tan, Xiao-Ting Cai, Yu-Xiang Wen, Hu Ma, Q. John Fu, Meng-Xin Leng, Yan-Pei Zhang, Li-Li Long, Ze-Qin Guo, De-Hua Wu, Jian-Guo Zhou, Zhong-Yi Dong
Publikováno v:
BMC Medicine, Vol 20, Iss 1, Pp 1-12 (2022)
Abstract Background Organ-specific metastatic context has not been incorporated into the clinical practice of guiding programmed death-(ligand) 1 [PD-(L)1] blockade, due to a lack of understanding of its predictive versus prognostic value. We aim at
Externí odkaz:
https://doaj.org/article/24a3b6c7bf874232b58096c5d956a366
Autor:
Shan Su, Mei-Feng Ye, Xiao-Ting Cai, Xue Bai, Zhi-Hao Huang, Si-Cong Ma, Jian-Jun Zou, Yu-Xiang Wen, Li-Juan Wu, Xue-Jun Guo, Xian-Lan Zhang, Wen-Chang Cen, Duo-Hua Su, Hui-Yi Huang, Zhong-Yi Dong
Publikováno v:
BMC Medicine, Vol 19, Iss 1, Pp 1-11 (2021)
Abstract Background It is not a rare clinical scenario to have patients presenting with coexisting malignant tumor and tuberculosis. Whether it is feasible to conduct programmed death-(ligand) 1 [PD-(L)1] inhibitors to these patients, especially thos
Externí odkaz:
https://doaj.org/article/895224225a4443428766e35a13dfa42b
Autor:
Si-Cong Ma, Hong-Bo Zhu, Jian Wang, Yan-Pei Zhang, Xue-Jun Guo, Li-Li Long, Ze-Qin Guo, De-Hua Wu, Zhong-Yi Dong, Xue Bai
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
PurposeDespite the success of targeted therapy in c-ros oncogene 1 (ROS1)-rearranged cancers, especially non-small cell lung cancer (NSCLC), the clinical significance of ROS1 de novo mutation has not yet been understood. We sought to elucidate the pr
Externí odkaz:
https://doaj.org/article/de34127cd04f47bc8097330ec0dbe84b
Autor:
Lin Zheng, Ling-Wei Zhu, Jie Jing, Jia-yao Guan, Ge-Jin Lu, Lin-Hong Xie, Xue Ji, Dong Chu, Yang Sun, Ping Chen, Xue-Jun Guo
Publikováno v:
Frontiers in Veterinary Science, Vol 8 (2021)
Migratory birds are recently recognized as Vibrio disease vectors, but may be widespread transporters of Vibrio strains. We isolated Vibrio cholerae (V. cholerae) and Vibrio metschnikovii (V. metschnikovii) strains from migratory bird epidemic sample
Externí odkaz:
https://doaj.org/article/f725531fa7254d79879525cb042bb21b
Autor:
Si-Cong Ma, Xin-Ran Tang, Li-Li Long, Xue Bai, Jian-Guo Zhou, Zhi-Jiao Duan, Jian Wang, Qiang John Fu, Hong-Bo Zhu, Xue-Jun Guo, Yan-Pei Zhang, Ze-Qin Guo, De-Hua Wu, Zhong-Yi Dong
Publikováno v:
OncoImmunology, Vol 10, Iss 1 (2021)
Objectives: Clinical benefits of immune-checkpoint blockade (ICB) versus standard chemotherapy have been established in unselected non-small cell lung cancer (NSCLC). However, the response to ICB therapy among patients is heterogeneous in clinical pr
Externí odkaz:
https://doaj.org/article/489c09595f1a41e4ad06be021b54b7d7
Autor:
Yue Yuan, Bing Liang, Bo-Wen Jiang, Ling-Wei Zhu, Tie-Cheng Wang, Yuan-Guo Li, Jun Liu, Xue-Jun Guo, Xue Ji, Yang Sun
Publikováno v:
PLoS ONE, Vol 16, Iss 12, p e0261444 (2021)
Migratory birds play an important role in the spread of multidrug-resistant (MDR) bacteria. To investigate the prevalence of MDR Escherichia coli in migratory birds in China and potential relationships with the environment, a total of 1387 samples (f
Externí odkaz:
https://doaj.org/article/ff705eb7907d41568f953f2b37fa9a70
Autor:
Yan-Hui Wei, Yu-Zhuo He, Xiao-Yan Lin, Fu-Xian Ren, Hong-Bin Zhu, Ying Cheng, Zhen Nan, Zheng-Biao Liu, Jing-Ya Yu, Xue-Jun Guo
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 8 (2020)
BackgroundLymphoma is a common hematological malignancy with many subtypes and considerable heterogeneity. Traditional treatments include chemotherapy, radiotherapy, and surgery. Patients with relapsed, refractory or advanced stage lymphoma have a di
Externí odkaz:
https://doaj.org/article/77a705eda74248639f9e0b81715008ab
Publikováno v:
PLoS ONE, Vol 11, Iss 3, p e0150551 (2016)
The aryl hydrocarbon receptor (AhR), a transcription factor of the bHLH/PAS family, has recently been demonstrated to regulate T cell differentiation. Whether AhR activation participates in allergic airway inflammation remains unknown. In the current
Externí odkaz:
https://doaj.org/article/6d152aed00a94ef38177385c89754480
Autor:
Ting-yu YUAN, Bing LIANG, Bo-wen JIANG, Shi-wen SUN, Yi-fan ZHOU, Ling-wei ZHU, Jun LIU, Xue-jun GUO, Xue JI, Yang SUN
Publikováno v:
Journal of Veterinary Medical Science. 85:371-378
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4c6121a25ddb20ee245a045c168e58a6
https://doi.org/10.1292/jvms.22-0410
https://doi.org/10.1292/jvms.22-0410